04/05/2024
3:30 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2024
7:16 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
3:55 PM | Iterum Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
01/30/2024
4:00 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
12/29/2023
3:30 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
8:00 AM | Dunne Michael W. (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
6:45 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
12/14/2023
6:30 AM | Iterum Therapeutics (Filer)
| Form DEF 14A | |
12/04/2023
4:15 PM | Iterum Therapeutics (Filer)
| Form PRE 14A | |
12/04/2023
7:30 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2023
4:00 PM | Dunne Michael W. (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2023
8:00 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2023
8:20 AM | Dunne Michael W. (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
8:22 AM | HUNT RONALD (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2023
6:31 AM | Iterum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/11/2023
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2023
6:07 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
07/06/2023
8:24 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
07/06/2023
8:25 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
07/03/2023
7:00 AM | HUNT RONALD (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
7:00 AM | Dunne Michael W. (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
3:49 PM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
06/05/2023
7:00 AM | Dunne Michael W. (Reporting)
Iterum Therapeutics (Issuer)
| Form 4/A | |
05/12/2023
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/12/2023
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
12:26 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
